The AMA issued separate codes for subfascial and subcutaneous implantation of a tibial neuromodulation device.
|Videos|October 9, 2020
Dried cranberry powder shows promise in overactive bladder
Author(s)Urology Times staff
Bilal Chughtai, MD, and Ahra Cho discuss a recent study evaluating the efficacy of dried cranberry powder in women with overactive bladder.
Advertisement
This interview features Bilal Chughtai, MD, and Ahra Cho. They discuss the recent Journal of Urology paper Efficacy of Daily Intake of Dried Cranberry 500 mg in Women with Overactive Bladder: A Randomized, Double-Blind, Placebo-Controlled Study, for which they served as study authors. Chughtai is an Associate Professor of Urology and an Associate Professor of Urology in Obstetrics and Gynecology at Weill Cornell Medicine, and Cho is assistant research coordinator at Weill Cornell Medicine Urology, New York.
Advertisement
Related to this article
Positive safety and efficacy data from 4 clinical studies supported the CE marking.
The safety and efficacy of vibegron are supported by data from the phase 3 COURAGE and EMPOWUR trials.
EG110A is an investigational DNA medicine under development for neurogenic detrusor overactivity with urinary incontinence.
Advertisement
Advertisement
Trending on Urology Times
1
AMA issues Category I CPT codes for implantable tibial neuromodulation in UUI
2
The UroOnc Minute: Key Updates to the AUA NMIBC Guideline, With Peter E. Clark, MD
3
Aglatimagene besadenovec shows sustained immune remodeling in localized prostate cancer
4
John Sfakianos, MD, on integrating ctDNA into bladder cancer trials
5